<DOC>
	<DOCNO>NCT02186743</DOCNO>
	<brief_summary>The primary objective clinical trial portion study ass whether individualized dietary plan base commercial food sensitivity assay provide specific benefit randomize control trial adult irritable bowel syndrome ( IBS ) .</brief_summary>
	<brief_title>Irritable Bowel Syndrome Food Sensitivity</brief_title>
	<detailed_description>This parallel group , randomize control trial , power assess change validate outcome adult patient symptomatic irritable bowel syndrome . Subjects receive dietary counseling ask adhere dietary instruction 4 week . Assessments occur baseline , 4-weeks , 8-weeks post-baseline .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>Between 1870 year age . Irritable Bowel Syndrome Rome III criterion . Stable dose ( 30 day ) concurrent IBS medication Agree make significant change diet study IBSSSS score &gt; 150 History major abdominal surgery History inflammatory bowel disease Antibiotic use within 1 month enrollment Radiation proctitis know poorly control medical condition could interfere bowel function Current use opioid pain medication ( except NSAIDs ) Previous experience participate dietary study IBS Current use medication know affected modest dietary change Vitamin C use &gt; 2000 mg/day Quercetin use &gt; 500 mg/day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Irritable Bowel Syndrome</keyword>
	<keyword>IBS</keyword>
	<keyword>Diet</keyword>
	<keyword>Food sensitivity</keyword>
</DOC>